Cargando…
High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641589/ https://www.ncbi.nlm.nih.gov/pubmed/36342722 http://dx.doi.org/10.1001/jamapediatrics.2022.4131 |
_version_ | 1784826114291531776 |
---|---|
author | Pathak, Kavya Narang, Claire Hwang, Thomas J. Espinoza, Juan C. Bourgeois, Florence T. |
author_facet | Pathak, Kavya Narang, Claire Hwang, Thomas J. Espinoza, Juan C. Bourgeois, Florence T. |
author_sort | Pathak, Kavya |
collection | PubMed |
description | This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021. |
format | Online Article Text |
id | pubmed-9641589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-96415892022-11-28 High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 Pathak, Kavya Narang, Claire Hwang, Thomas J. Espinoza, Juan C. Bourgeois, Florence T. JAMA Pediatr Research Letter This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021. American Medical Association 2022-11-07 2023-01 /pmc/articles/PMC9641589/ /pubmed/36342722 http://dx.doi.org/10.1001/jamapediatrics.2022.4131 Text en Copyright 2022 Pathak K et al. JAMA Pediatrics. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Research Letter Pathak, Kavya Narang, Claire Hwang, Thomas J. Espinoza, Juan C. Bourgeois, Florence T. High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 |
title | High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 |
title_full | High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 |
title_fullStr | High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 |
title_full_unstemmed | High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 |
title_short | High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 |
title_sort | high-risk therapeutic devices approved by the us food and drug administration for use in children and adolescents from 2016 to 2021 |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641589/ https://www.ncbi.nlm.nih.gov/pubmed/36342722 http://dx.doi.org/10.1001/jamapediatrics.2022.4131 |
work_keys_str_mv | AT pathakkavya highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021 AT narangclaire highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021 AT hwangthomasj highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021 AT espinozajuanc highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021 AT bourgeoisflorencet highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021 |